| Year |
Citation |
Score |
| 2023 |
Ortí G, Gras L, Koster L, Kulagin A, Byrne J, Apperley JF, Halaburda K, Blau IW, Clark A, Kröger N, Griskevicius L, Carlson K, Collin M, Bloor A, Raiola AM, ... ... Sakellari I, et al. Graft-versus-Host Disease Prophylaxis with Post Transplant Cyclophosphamide in Chronic Myeloid Leukemia patients undergoing Allogeneic Hematopoietic Cell Transplant from either an Unrelated or Mismatched Related Donor: a comparative study from the Chr... Transplantation and Cellular Therapy. PMID 37783337 DOI: 10.1016/j.jtct.2023.09.019 |
0.323 |
|
| 2020 |
Gavriilaki M, Sakellari I, Anagnostopoulos A, Gavriilaki E. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 26: 1738-1746. PMID 32447043 DOI: 10.1016/J.Bbmt.2020.05.011 |
0.33 |
|
| 2020 |
Gavriilaki E, Touloumenidou T, Sakellari I, Batsis I, Mallouri D, Psomopoulos F, Tsagiopoulou M, Koutra M, Yannaki E, Papalexandri A, Taylor P, Nikolousis E, Stamouli M, Holbro A, Baltadakis I, et al. Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy. Thrombosis and Haemostasis. PMID 32131130 DOI: 10.1055/S-0040-1702225 |
0.363 |
|
| 2019 |
Sakellari I, Kabouraki E, Karanikolopoulos D, Droulias S, Farsari M, Loukakos P, Vamvakaki M, Gray D. Quantum dot based 3D printed woodpile photonic crystals tuned for the visible. Nanoscale Advances. 1: 3413-3423. PMID 36133530 DOI: 10.1039/c9na00357f |
0.7 |
|
| 2019 |
Gavriilaki E, Sakellari I. Kidney Disease after Allogeneic Hematopoietic Cell Transplantation: In Search of the Truth. Acta Haematologica. 1-2. PMID 31794970 DOI: 10.1159/000504523 |
0.371 |
|
| 2019 |
Gavriilaki E, Sakellari I, Karafoulidou I, Pasteli N, Batsis I, Mallouri D, Lazaridou A, Iskas M, Vardi A, Papalexandri A, Tsompanakou A, Papaemmanouil S, Ilias A, Anagnostopoulos A. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease. International Journal of Hematology. 110: 529-532. PMID 31586304 DOI: 10.1007/S12185-019-02750-7 |
0.392 |
|
| 2019 |
Gavriilaki M, Mainou M, Gavriilaki E, Haidich AB, Papagiannopoulos S, Sakellari I, Anagnostopoulos A, Kimiskidis V. Neurologic complications after allogeneic transplantation: a meta-analysis. Annals of Clinical and Translational Neurology. 6: 2037-2047. PMID 31560177 DOI: 10.1002/Acn3.50909 |
0.371 |
|
| 2019 |
Gavriilaki M, Sakellari I, Gavriilaki E, Kimiskidis VK, Anagnostopoulos A. Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents. Stem Cells International. 2019: 5840286. PMID 31341484 DOI: 10.1155/2019/5840286 |
0.318 |
|
| 2019 |
Gavriilaki E, Chrysanthopoulou A, Sakellari I, Batsis I, Mallouri D, Touloumenidou T, Papalexandri A, Mitsios A, Arampatzioglou A, Ritis K, Brodsky RA, Mitroulis I, Anagnostopoulos A. Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy. Thrombosis and Haemostasis. 119: 1433-1440. PMID 31266080 DOI: 10.1055/S-0039-1692721 |
0.361 |
|
| 2019 |
Sakellari I, Gavriilaki E, Batsis I, Mallouri D, Gavriilaki M, Apostolou C, Iskas M, Voutiadou G, Bouziana S, Bousiou Z, Constantinou V, Masmanidou M, Sotiropoulos D, Yannaki E, Lalayanni C, et al. Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 25: 1756-1760. PMID 31128329 DOI: 10.1016/J.Bbmt.2019.05.018 |
0.408 |
|
| 2019 |
Sakellari I, Gavriilaki E, Papagiannopoulos S, Gavriilaki M, Batsis I, Mallouri D, Vardi A, Constantinou V, Masmanidou M, Yannaki E, Smias C, Geroukis T, Kazis D, Kimiskidis V, Anagnostopoulos A. Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality. Journal of Neurology. 266: 1960-1972. PMID 31087160 DOI: 10.1007/S00415-019-09372-3 |
0.36 |
|
| 2019 |
Papalexandri A, Karypidou M, Stalika E, Kotta K, Touloumenidou T, Zerva P, Paleta A, Mallouri D, Batsis I, Sakellari I, Kotsianidis I, Anagnostopoulos A, Hadzidimitriou A, Margaritis D, Stamatopoulos K. Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath? Leukemia & Lymphoma. 1-8. PMID 30652530 DOI: 10.1080/10428194.2018.1543881 |
0.31 |
|
| 2019 |
Sakellari I, Gavriilaki E, Bouziana S, Constantinou V, Mallouri D, Vardi A, Marvaki A, Batsis I, Sotiropoulos D, Anagnostopoulos A. BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma. Bone Marrow Transplantation. 54: 921-923. PMID 30410083 DOI: 10.1038/S41409-018-0395-Y |
0.392 |
|
| 2019 |
Gavriilaki M, Mainou M, Gavriilaki E, Haidich A, Papagiannopoulos S, Sakellari I, Anagnostopoulos A, Kimiskidis V. Spectrum of Neurologic Complications after Allogeneic Hematopoietic Cell Transplantation for Hematologic Diseases in Adults: Systematic Review and Meta-Analysis Blood. 134: 5692-5692. DOI: 10.1182/Blood-2019-128641 |
0.354 |
|
| 2019 |
Gavriilaki E, Sakellari I, Chatziconstantinou T, Mallouri D, Batsis I, Vardi A, Bousiou Z, Koravou E, Masmanidou M, Touloumenidou T, Papalexandri L, Athanasiadou A, Yannaki E, Anagnostopoulos A. Easix Is Strongly Associated with Complement Activation and Overall Survival in Adult Allogeneic Hematopoietic Cell Transplantation Recipients Blood. 134: 4520-4520. DOI: 10.1182/Blood-2019-125332 |
0.378 |
|
| 2019 |
Gavriilaki E, Sakellari I, Chatziconstantinou T, Mallouri D, Batsis I, Katsifa E, Papadimitriou S, Panteliadou A, Baldoumi E, Demosthenous C, Bousiou Z, Constantinou V, Sotiropoulos D, Anagnostopoulos A. Risk Factors and Outcomes of Klebsiella Pneumoniae Infection before and after Allogeneic Hematopoietic Cell Transplantation Blood. 134: 4502-4502. DOI: 10.1182/Blood-2019-125320 |
0.338 |
|
| 2018 |
Sakellari I, Gavriilaki E, Batsis I, Mallouri D, Panteliadou AK, Lazaridou A, Vardi A, Constantinou V, Yannaki E, Papalexandri A, Kaloyannidis P, Smias C, Anagnostopoulos A. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study. Journal of Clinical Apheresis. 33: 654-660. PMID 30394564 DOI: 10.1002/Jca.21660 |
0.371 |
|
| 2018 |
Gavriilaki E, Sakellari I, Batsis I, Mallouri D, Bousiou Z, Vardi A, Yannaki E, Constantinou V, Tsompanakou A, Vadikoliou C, Kaloyannidis P, Bamihas G, Anagnostopoulos A. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation. Clinical Transplantation. 32: e13371. PMID 30080283 DOI: 10.1111/Ctr.13371 |
0.406 |
|
| 2018 |
Tsirigotis P, Vassilakopoulos T, Batsis I, Bousiou Z, Gkirkas K, Sakellari I, Kaloyannidis P, Roussou P, Pangalis GA, Moschogiannis M, Vassilopoulos G, Repousis P, Megalakaki A, Michalis E, Kalpadakis C, et al. Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis. Hematological Oncology. PMID 29882363 DOI: 10.1002/Hon.2521 |
0.317 |
|
| 2018 |
Sakellari I, Gavriilaki E, Chatziioannou K, Papathanasiou M, Mallouri D, Batsis I, Bousiou Z, Bouziana S, Constantinou V, Douka V, Apostolou C, Iskas M, Lalayanni C, Athanasiadou A, Sotiropoulos D, et al. Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study. Annals of Hematology. 97: 1987-1994. PMID 29869673 DOI: 10.1007/S00277-018-3383-9 |
0.417 |
|
| 2018 |
Sakellari I, Papalexandri A, Mallouri D, Batsis I, Iskas M, Xochelli A, Marvaki A, Gavriilaki E, Vardi A, Zerva P, Touloumenidou T, Anagnostopoulos A. Donor EBV at the time of hematopoietic cell transplantation: Is it time to adopt molecular assays? Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 102: 32-33. PMID 29482045 DOI: 10.1016/J.Jcv.2018.02.012 |
0.357 |
|
| 2018 |
Angelopoulou MK, Vassilakopoulos TP, Batsis I, Sakellari I, Gkirkas K, Pappa V, Giannoulia P, Apostolidis I, Apostolopoulos C, Roussou P, Panayiotidis P, Dimou M, Kyrtsonis MC, Palassopoulou M, Vassilopoulos G, et al. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience. Hematological Oncology. 36: 174-181. PMID 28219112 DOI: 10.1002/Hon.2383 |
0.35 |
|
| 2018 |
Vardi A, Sakellari I, Lazaridou A, Papalexandri A, Batsis I, Mallouri D, Marvaki A, Touloumenidou T, Yannaki E, Iskas M, Constantinou V, Gavriilaki E, Papaemmanouil S, Anagnostopoulos A. EBV-Related Post-Transplant Lymphoproliferative Disease in Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience and Considerations Regarding CNS Involvement Blood. 132: 5706-5706. DOI: 10.1182/Blood-2018-99-118008 |
0.399 |
|
| 2018 |
Sakellari I, Bousiou Z, Lazaridou A, Gavriilaki E, Batsis I, Mallouri D, Iskas M, Stavroyianni N, Marvaki A, Pilavaki M, Papaemmanouil S, Anagnostopoulos A. Disease Risk Index Is Independently Associated with Long-Term Outcomes of Allogeneic Transplantation Post Reduced-Intensity Conditioning in Lymphoid Malignancies Blood. 132: 5773-5773. DOI: 10.1182/Blood-2018-99-116659 |
0.342 |
|
| 2018 |
Gavriilaki E, Touloumenidou T, Sakellari I, Batsis I, Mallouri D, Psomopoulos F, Kotouza M, Koutra M, Yannaki E, Papalexandri A, Stamouli M, Holbro A, Baltadakis I, Liga M, Spyridonidis A, et al. Pre-Transplant Genetic Susceptibility in Adult Allogeneic Hematopoietic Cell Transplant Recipients: Incidence and Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy Blood. 132: 3401-3401. DOI: 10.1182/Blood-2018-99-112041 |
0.376 |
|
| 2018 |
Sakellari I, Gavriilaki E, Papagiannopoulos S, Gavriilaki M, Batsis I, Mallouri D, Vardi A, Constantinou V, Iskas M, Masmanidou M, Yannaki E, Geroukis T, Kazis D, Kimiskidis V, Anagnostopoulos A. Neurological Adverse Events Determine Morbidity and Mortality Post Allogeneic Hematopoietic Cell Transplantation Blood. 132: 5732-5732. DOI: 10.1182/Blood-2018-99-112032 |
0.392 |
|
| 2018 |
Seniutinas G, Weber A, Padeste C, Sakellari I, Farsari M, David C. Beyond 100 nm resolution in 3D laser lithography — Post processing solutions Microelectronic Engineering. 191: 25-31. DOI: 10.1016/J.Mee.2018.01.018 |
0.302 |
|
| 2017 |
Sakellari I, Batsis I, Bousiou Z, Mallouri D, Constantinou V, Gavriilaki E, Smias C, Yannaki E, Kaloyannidis P, Papaioannou G, Stavroyianni N, Syrigou A, Sotiropoulos D, Fylaktou A, Tsompanakou A, et al. The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies. Clinical Lymphoma, Myeloma & Leukemia. 17: 658-666. PMID 28716402 DOI: 10.1016/J.Clml.2017.06.008 |
0.396 |
|
| 2017 |
Gavriilaki E, Sakellari I, Anagnostopoulos A, Brodsky RA. Transplant-associated thrombotic microangiopathy: opening Pandora's box. Bone Marrow Transplantation. 52: 1355-1360. PMID 28287636 DOI: 10.1038/Bmt.2017.39 |
0.382 |
|
| 2017 |
Sakellari I, Gavriilaki E, Kaliou M, Mallouri D, Batsis I, Yannaki E, Smias C, Sotiropoulos D, Tsorlini E, Anagnostopoulos A. Candida is an emerging pathogen beyond the neutropenic period of allogeneic hematopoietic cell transplantation. Clinical Transplantation. 31. PMID 28224660 DOI: 10.1111/Ctr.12921 |
0.379 |
|
| 2017 |
Pavlů J, Labopin M, Zoellner AK, Sakellari I, Stelljes M, Finke J, Fanin R, Stuhler G, Afanasyev BV, Bloor AJ, Anagnostopoulos A, Mohty M, Giebel S, Nagler A. Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT. Cancer. 123: 1965-1970. PMID 28211939 DOI: 10.1002/Cncr.30604 |
0.401 |
|
| 2017 |
Sakellari I, Mallouri D, Gavriilaki E, Batsis I, Kaliou M, Constantinou V, Papalexandri A, Lalayanni C, Vadikolia C, Athanasiadou A, Yannaki E, Sotiropoulos D, Smias C, Anagnostopoulos A. Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 23: 445-451. PMID 27914967 DOI: 10.1016/J.Bbmt.2016.11.023 |
0.372 |
|
| 2017 |
Sakellari I, Gavriilaki E, Boussiou Z, Batsis I, Mallouri D, Constantinou V, Kaloyannidis K, Yannaki E, Bamihas G, Anagnostopoulos A. Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases. Hematological Oncology. 35: 932-934. PMID 27641429 DOI: 10.1002/Hon.2346 |
0.383 |
|
| 2017 |
Sakellari I, Kabouraki E, Gray D, Vamvakaki M, Farsari M. Quantum dot based 3D photonic devices Proceedings of Spie. 10115. DOI: 10.1117/12.2254835 |
0.36 |
|
| 2017 |
Vadikoliou C, Bousiou Z, Kaliou M, Athanasiadou A, Sakellari I, Lalayanni C, Anagnostopoulos A. Secondary Malignancies in Patients Undergoing Autologous Hematopoietic Cell Transplant for Multiple Myeloma Clinical Lymphoma, Myeloma & Leukemia. 17. DOI: 10.1016/J.Clml.2017.03.203 |
0.406 |
|
| 2017 |
Mallouri D, Sakellari I, Gavriilaki E, Konstantinou V, Batsis I, Kaliou M, Apostolou C, Kalaitzidou V, Bouinta A, Smias C, Kaloyannidis P, Sotiropoulos D, Yannaki E, Anagnostopoulos A. Donor Lymphocyte Infusions' Efficacy in Relapsed Acute Myeloid Leukemia Post Allogeneic Hematopoietic Cell Transplantation: A Single Center Long-Term Analysis Biology of Blood and Marrow Transplantation. 23. DOI: 10.1016/J.Bbmt.2016.12.328 |
0.39 |
|
| 2016 |
Sakellari I, Batsis I, Boussiouu Z, Mallouri D, Konstantinou V, Iskas M, Vardi A, Papadimitriou S, Panteliadou A, Smias C, Yannaki E, Fylaktou A, Tsompanakou A, Vadikoliou C, Kaloyannidis P, et al. Transplant-Associated Thrombotic Microangiopathy: Prevalence, Prognostic Factors and Treatment Outcomes in Unrelated Allogeneic Transplant for Hematologic Diseases Blood. 128: 982-982. DOI: 10.1182/Blood.V128.22.982.982 |
0.416 |
|
| 2016 |
Sakellari I, Konstantinou V, Gavriilaki E, Mallouri D, Batsis I, Kalaitzidou V, Apostolou C, Kaliou M, Bouinta A, Smias C, Kaloyannidis P, Sotiropoulos D, Yannaki E, Anagnostopoulos A. Efficacy and Toxicity of Donor Lymphocyte Infusions in Relapsed Acute Myeloid Leukemia Post Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience Blood. 128: 5804-5804. DOI: 10.1182/Blood.V128.22.5804.5804 |
0.428 |
|
| 2016 |
Bousiou Z, Syrigou A, Lalayianni C, Smias C, Sakellari I, Tsirou K, Leontopoulos K, Kalaitzidou V, Tsorlini E, Anagnostopoulos A, Sotiropoulos D. Two-Year Surveillance Study of Nosocomial Infections in Patients with Hematological Malignancies: Risk Factors for Antimicrobial Resistance and Their Impact in Mortality Blood. 128: 4892-4892. DOI: 10.1182/Blood.V128.22.4892.4892 |
0.32 |
|
| 2016 |
Sakellari I, Papalexandri A, Douka V, Papathanasiou M, Kotta K, Sotiropoulos D, Karypidou M, Paleta A, Mallouri D, Batsis I, Yannaki E, Touloumenidou T, Tsompanakou A, Anagnostopoulos A. Minimal Residual Disease Monitoring By Two Sensitive Techniques May Contribute to Improved Outcome of Allogeneic Transplantation for Ph(-) Acute Lymphoblastic Leukemia Biology of Blood and Marrow Transplantation. 22. DOI: 10.1016/J.Bbmt.2015.11.766 |
0.335 |
|
| 2015 |
Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A, Kyrcz-Krzemien S, Daikeler T, Alexander T, Finke J, Badoglio M, et al. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? Bone Marrow Transplantation. PMID 26642332 DOI: 10.1038/Bmt.2015.299 |
0.344 |
|
| 2015 |
Sakellari I, Angelopoulou M, Tsopra O, Dervenoulas I, Tsirigotis P, Spyridonidis A, Liga M, Tsionos K, Anargyrou K, Pouli A, Anagnostopoulos A. A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation. Annals of Hematology. 94: 1733-40. PMID 26141369 DOI: 10.1007/S00277-015-2437-5 |
0.329 |
|
| 2015 |
Sakellari I, Mallouri D, Batsis I, Apostolou C, Konstantinou V, Abela EM, Douka V, Marvaki A, Karypidis K, Iskas M, Baliakas P, Kaloyannidis P, Yannaki E, Sotiropoulos D, Kouvatseas G, et al. Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas. Leukemia & Lymphoma. 56: 3071-81. PMID 25760637 DOI: 10.3109/10428194.2015.1028054 |
0.36 |
|
| 2015 |
Sakellari I, Mallouri D, Constantinou VC, Iskas M, Batsis I, Papadimitriou S, Panteliadou K, Palladas P, Datseris I, Anagnostopoulos A. The Predictive Significance of Early Metabolic Remission Post Autologous Hematopoietic Transplantation in Lymphomas Conditioned with Either BEAM or a Busulfan-Based Regimen Blood. 126: 1984-1984. DOI: 10.1182/Blood.V126.23.1984.1984 |
0.326 |
|
| 2015 |
Batsis I, Sakellari I, Papalexandri A, Mallouri D, Charalampidou S, Kaliou M, Afisidis A, Gavriilaki E, Constantinou VC, Yannaki E, Kaloyannidis P, Apostolou C, Sotiropoulos D, Vadikolia C, Smias C, et al. Survival Advantage with Comparable Complete Chimerism Patterns in Reduced Toxicity Treosulfan-Based Vs Reduced Intensity Busulfan-Based Conditinioning Regimen in AML/MDS Patients Undergoing Allogeneic Haematopoietic Cell Transplantation Blood. 126: 1914-1914. DOI: 10.1182/Blood.V126.23.1914.1914 |
0.392 |
|
| 2015 |
Sakellari I, Mallouri D, Batsis I, Charalampidou S, Kaliou M, Afisidis A, Gavriilaki E, Constantinou V, Yannaki E, Kaloyannidis P, Apostolou C, Sotiropoulos D, Papalexandri A, Vadikoliou C, Smias C, et al. 130 Reduced Toxicity Treosulfan-Based Vs. Reduced Intensity Busulfan-Based Conditioning Regimen In Aml/Mds Patients Undergoing Allogeneic Haematopoietic Cell Transplantation: Preliminary Results Of A Single Centre Experience Leukemia Research. 39. DOI: 10.1016/S0145-2126(15)30131-4 |
0.398 |
|
| 2015 |
Sotiropoulos D, Bouinta A, Karavalakis G, Gounopoulos S, Stafylidis V, Dontsiou A, Sakellari I, Anagnostopoulos A. The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.582 |
0.365 |
|
| 2015 |
Papalexandri A, Sakellari I, Apostolou C, Boussiou Z, Sotiropoulos D, Charalampidou S, Zerva P, Touloumenidou T, Konstantinou V, Mallouri D, Batsis I, Anagnostopoulos A. Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.425 |
0.351 |
|
| 2014 |
Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Stanciu R, Sakellari I, Schroers R, Scherer HU, Kyrcz-Krzemien S, Daikeler T, Alexander T, Finke J, Badoglio M, Snowden JA, et al. Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study? Blood. 124: 2517-2517. DOI: 10.1182/Blood.V124.21.2517.2517 |
0.372 |
|
| 2013 |
Sakellari I, Barbouti A, Bamichas G, Mallouri D, Kaloyannidis P, Fragidis S, Batsis I, Apostolou C, Karpouza A, Yannaki E, Smias C, Sombolos K, Anagnostopoulos A. GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation. Bone Marrow Transplantation. 48: 1329-34. PMID 23584436 DOI: 10.1038/Bmt.2013.55 |
0.364 |
|
| 2013 |
Ioakimidou A, Vyzantiadis TA, Sakellari I, Arabatzis M, Smias C, Douka V, Velegraki A, Anagnostopoulos A, Malissiovas N. An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit. Diagnostic Microbiology and Infectious Disease. 75: 313-6. PMID 23290506 DOI: 10.1016/J.Diagmicrobio.2012.11.015 |
0.305 |
|
| 2013 |
Sakellari I, Mallouri D, Batsis I, Apostolou C, Konstantinou V, Abela EM, Douka V, Marvaki A, Karypidis K, Michail I, Baliakas P, Kaloyannidis P, Yannaki E, Kouvatseas G, Smias C, et al. A matched pair analysis of conditioning BuEM versus BEAM in autologous haematopoietic cell transplantation for lymphomas in terms of toxicity and efficacy. Journal of Clinical Oncology. 31: 8567-8567. DOI: 10.1200/Jco.2013.31.15_Suppl.8567 |
0.354 |
|
| 2013 |
Sakellari I, Mallouri D, Sotiropoulos D, Batsis I, Konstantinou V, Iskas M, Baliakas P, Karypidis K, Georgiadou E, Douka V, Abela E, Marvaki A, Apostolou C, Yannaki E, Kaloyannidis P, et al. Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.304 |
0.365 |
|
| 2012 |
Sakellari I, Kabouraki E, Gray D, Purlys V, Fotakis C, Pikulin A, Bityurin N, Vamvakaki M, Farsari M. Diffusion-assisted high-resolution direct femtosecond laser writing. Acs Nano. 6: 2302-11. PMID 22324511 DOI: 10.1021/Nn204454C |
0.501 |
|
| 2012 |
Vasilantonakis N, Terzaki K, Sakellari I, Purlys V, Gray D, Soukoulis CM, Vamvakaki M, Kafesaki M, Farsari M. Three-dimensional metallic photonic crystals with optical bandgaps. Advanced Materials (Deerfield Beach, Fla.). 24: 1101-5. PMID 22278944 DOI: 10.1002/Adma.201104778 |
0.319 |
|
| 2012 |
Tsirigotis P, Kaloyannidis P, Papalexandri A, Baltadakis I, Karakasis D, Batsis I, Sakellari I, Kitra V, Goussetis E, Papageorgiou S, Spyridonidis A, Graphakos S, Harhalakis N, Dervenoulas I, Anagnostopoulos A. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology. Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society For Haemapheresis. 46: 173-80. PMID 22036202 DOI: 10.1016/J.Transci.2011.09.001 |
0.324 |
|
| 2012 |
Kaloyannidis P, Voutiadou G, Baltadakis I, Tsirigotis P, Spyridonidis A, Repousis P, Balta A, Tsimberis S, Karakasis D, Sakellari I, Dervenoulas I, Harhalakis N, Anagnostopoulos A. Outcomes of Hodgkin's lymphoma patients with relapse or progression following autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 451-7. PMID 21803018 DOI: 10.1016/J.Bbmt.2011.07.020 |
0.393 |
|
| 2012 |
Sakellari I, Mallouri D, Ioannis B, Varnavas C, Michalis I, Panayotis B, Kyriakos K, Elissavet G, Vassiliki D, Elma A, Marvaki A, Chrysoula A, Sotiropoulos D, Yannaki E, Kaloyannidis P, et al. Efficacy and Toxicity of Conditioning Regimens BEAM and BEM in Autologous Hematopoietic Cell Transplantation for Lymphomas: Preliminary Results of a Comparative (Matched Pair) Analysis Blood. 120: 4530-4530. DOI: 10.1182/Blood.V120.21.4530.4530 |
0.329 |
|
| 2012 |
Bickauskaite G, Manousidaki M, Terzaki K, Kambouraki E, Sakellari I, Vasilantonakis N, Gray D, Soukoulis CM, Fotakis C, Vamvakaki M, Kafesaki M, Farsari M, Pikulin A, Bityurin N. 3D photonic nanostructures via diffusion-assisted direct fs laser writing Advances in Optoelectronics. 2012. DOI: 10.1155/2012/927931 |
0.51 |
|
| 2012 |
Sakellari I, Kabouraki E, Gray D, Fotakis C, Pikulin A, Bityurin N, Vamvakaki M, Farsari M. High-resolution 3D woodpile structures by direct fs laser writing Proceedings of Spie. 8456. DOI: 10.1117/12.930155 |
0.523 |
|
| 2011 |
Kountouras J, Sakellari I, Tsarouchas G, Tsiaousi E, Michael S, Zavos C, Anastasiadou K, Stergiopoulos C, Anagnostopoulos A. Autologous haematopoietic stem cell transplantation in a patient with refractory Crohn's disease. Journal of Crohn's & Colitis. 5: 275-6. PMID 21575901 DOI: 10.1016/J.Crohns.2011.03.004 |
0.387 |
|
| 2011 |
Fassas A, Kimiskidis VK, Sakellari I, Kapinas K, Anagnostopoulos A, Tsimourtou V, Sotirakoglou K, Kazis A. Long-term results of stem cell transplantation for MS: a single-center experience. Neurology. 76: 1066-70. PMID 21422458 DOI: 10.1212/Wnl.0B013E318211C537 |
0.357 |
|
| 2011 |
Kaloyannidis P, Konstantinou V, Georgiadou E, Zervou F, Batsis I, Mallouri D, Yannaki E, Papathanasiou M, Xoheli A, Sakellari I, Kiriazis G, Anagnostopoulos A. Impaired Antibody RESPONSE FOLLOWING VACCINATION Against Hepatitis-B VIRUS In Autografted PATIENTS for Hematologic Malignancies: PRELIMINARY RESULTS Blood. 118: 1999-1999. DOI: 10.1182/Blood.V118.21.1999.1999 |
0.301 |
|
| 2011 |
Malinauskas M, Gaidukevičiūtė A, Purlys V, Žukauskas A, Sakellari I, Kabouraki E, Candiani A, Gray D, Pissadakis S, Gadonas R, Piskarskas A, Fotakis C, Vamvakaki M, Farsari M. Direct laser writing of microoptical structures using a Ge-containing hybrid material Metamaterials. 5: 135-140. DOI: 10.1016/J.Metmat.2011.04.002 |
0.511 |
|
| 2010 |
Kaloyannidis P, Yannaki E, Sakellari I, Bitzioni E, Athanasiadou A, Mallouri D, Anagnostopoulos A. The impact of desferrioxamine postallogeneic hematopoietic cell transplantation in relapse incidence and disease-free survival: a retrospective analysis. Transplantation. 89: 472-9. PMID 20177351 DOI: 10.1097/Tp.0B013E3181C42944 |
0.41 |
|
| 2010 |
Chatzidimitriou D, Gavriilaki E, Sakellari I, Diza E. Hematopoietic cell transplantation and emerging viral infections. Journal of Medical Virology. 82: 528-538. PMID 20087928 DOI: 10.1002/Jmv.21696 |
0.343 |
|
| 2010 |
Farsari M, Sakellari I, Gray D, Vamvakaki M, Fotakis C, Ovsianikov A, Chichkov BN. Three-dimensional direct writing of novel sol-gel composites for photonics applications International Journal of Nanomanufacturing. 6: 164. DOI: 10.1504/Ijnm.2010.034781 |
0.539 |
|
| 2010 |
Sakellari I, Apostolou C, Mallouri D, Athanasiadou A, Batsis I, Smias C, Yannaki E, Lalayanni C, Syrigou A, Stavrogianni N, Vadikolia C, Saloum R, Fassas A, Anagnostopoulos A. OUTCOME of Allogeneic Hematopoietic CELL TRANSPLANTATION for AML: A Single CENTER Retrospective ANALYSIS. Blood. 116: 4567-4567. DOI: 10.1182/Blood.V116.21.4567.4567 |
0.355 |
|
| 2010 |
Mallouri D, Sakellari I, Apostolou C, Baliakas P, Papalexandri A, Tsobanakou A, Batsis I, Yannaki E, Smias C, Sotiropoulos D, Fassas A, Anagnostopoulos A. Successful Hematopoietic STEM CELL Mobilization with GRANULOCYTE Colony Stimulating FACTOR PLUS Plerixafor (MOZOBIL, AMD3100) IN POOR Mobilizers: A Single CENTER STUDY Blood. 116: 4444-4444. DOI: 10.1182/Blood.V116.21.4444.4444 |
0.346 |
|
| 2010 |
Mallouri D, Sakellari I, Batsis I, Konstantinou V, Baliakas P, Antoniou A, Apostolou C, Anagnostopoulos A, Fassas A. Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy Blood. 116: 1324-1324. DOI: 10.1182/Blood.V116.21.1324.1324 |
0.384 |
|
| 2010 |
Papalexandri A, Apostolou C, Voutiadou G, Touloumenidou T, Zorbas I, Batsis I, Smias C, Stalika E, Paleta A, Sakellari I, Anagnostopoulos A. Chimerism Kinetics of Unfractionated Bone Marrow In the First Year After Allogeneic Hematopoietic Cell Transplantation Is Predictive of Relapse In Patients with AML and MDS. Blood. 116: 1297-1297. DOI: 10.1182/Blood.V116.21.1297.1297 |
0.385 |
|
| 2010 |
Sakellari I, Gaidukeviciute A, Giakoumaki A, Gray D, Fotakis C, Farsari M, Vamvakaki M, Reinhardt C, Ovsianikov A, Chichkov BN. Two-photon polymerization of titanium-containing sol-gel composites for three-dimensional structure fabrication Applied Physics A. 100: 359-364. DOI: 10.1007/S00339-010-5864-0 |
0.505 |
|
| 2009 |
Papalexandri A, Touloumenidou T, Zorbas I, Gounari M, Zerva P, Smias C, Apostolou C, Batsis I, Kaloyannidis P, Sakellari I, Anagnostopoulos A. Molecular Detection of CMV in Biological Fluids Other Than Plasma. Clinical Relevance After Allogeneic Hematopoietic Cell Transplantation. Blood. 114: 2240-2240. DOI: 10.1182/Blood.V114.22.2240.2240 |
0.315 |
|
| 2009 |
Sakellari I, Gaidukeviciute A, Giakoumaki A, Gray D, Fotakis C, Vamvakaki M, Farsari M, Reinhardt C, Ovsianikov A, Chichkov BN. Direct laser writing of photonic nanostructures Proceedings of Spie. 7392. DOI: 10.1117/12.825560 |
0.511 |
|
| 2008 |
Ovsianikov A, Viertl J, Chichkov B, Oubaha M, MacCraith B, Sakellari I, Giakoumaki A, Gray D, Vamvakaki M, Farsari M, Fotakis C. Ultra-low shrinkage hybrid photosensitive material for two-photon polymerization microfabrication. Acs Nano. 2: 2257-62. PMID 19206391 DOI: 10.1021/Nn800451W |
0.537 |
|
| 2008 |
Kaloyannidis P, Mallouri D, Hatziioannou K, Batsis I, Yannaki E, Papavasileiou P, Sakellari I. low body mass index is an independent risk factor for transplant-associated microangiopathy following total-body irradiation-based conditioning regimens. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1076-1078. PMID 18721772 DOI: 10.1016/J.Bbmt.2008.05.022 |
0.303 |
|
| 2008 |
Kimiskidis V, Sakellari I, Tsimourtou V, Kapina V, Papagiannopoulos S, Kazis D, Vlaikidis N, Anagnostopoulos A, Fassas A. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome Multiple Sclerosis Journal. 14: 278-283. PMID 17942513 DOI: 10.1177/1352458507082604 |
0.373 |
|
| 2008 |
Kaloyannidis P, Yannaki E, Mpitzioni A, Batsis I, Mallouri D, Bartzoudis D, Sakellari I, Anagnostopoulos A. Desferrioxamine Administration Post Allogeneic Stem Cell Transplantation Reduces the Relapse Risk and Improves the Disease Free Survival. Blood. 112: 3254-3254. DOI: 10.1182/Blood.V112.11.3254.3254 |
0.397 |
|
| 2008 |
Ovsianikov A, Gaidukeviciute A, Chichkov B, Oubaha M, MacCraith BD, Sakellari I, Giakoumaki A, Gray D, Vamvakaki M, Farsari M, Fotakis C. Two-Photon Polymerization of Hybrid Sol-Gel Materials for Photonics Applications Laser Chemistry. 2008: 493059. DOI: 10.1155/2008/493059 |
0.541 |
|
| 2008 |
Farsari M, Ovsianikov A, Vamvakaki M, Sakellari I, Gray D, Chichkov BN, Fotakis C. Fabrication of three-dimensional photonic crystal structures containing an active nonlinear optical chromophore Applied Physics A. 93: 11-15. DOI: 10.1007/S00339-008-4642-8 |
0.537 |
|
| 2007 |
Kaloyannidis P, Batsis I, Yannaki E, Adamidou D, Bartzoudis D, Papathanasiou M, Mallouri D, Sakellari I, Fassas A, Anagnostopoulos A. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1049-56. PMID 17697967 DOI: 10.1016/J.Bbmt.2007.05.009 |
0.325 |
|
| 2007 |
Claviez A, Canals C, Boogaerts M, Stein J, Mackinnon S, Martino R, Pession A, Slavin S, Craddock C, Sakellari I, Corradini P, Rambaldi A, Suttorp M, Dini G, Sureda A, et al. The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin’s Lymphoma: An EBMT Study on 151 Patients. Blood. 110: 3061-3061. DOI: 10.1182/Blood.V110.11.3061.3061 |
0.407 |
|
| 2006 |
Batsis I, Yannaki E, Kaloyannidis P, Sakellari I, Smias C, Georgoulis I, Fassas A, Anagnostopoulos A. Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation. Thrombosis Research. 118: 611-8. PMID 16330084 DOI: 10.1016/J.Thromres.2005.10.010 |
0.319 |
|
| 2006 |
Kaloyannidis P, Yannaki E, Batsis I, Adamidou D, Bartzoudis D, Papathanasiou M, Mallouri D, Sakellari I, Fassas A, Anagnostopoulos A. Immunized Against Hepatitis B Virus Allografted Recipients Are at High Risk for Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer: A Study of 82 Allografted Long Term Survivors. Blood. 108: 2862-2862. DOI: 10.1182/Blood.V108.11.2862.2862 |
0.339 |
|
| 2005 |
Somali M, Mpatakoias V, Avramides A, Sakellari I, Kaloyannidis P, Smias C, Anagnostopoulos A, Kourtis A, Rousso D, Panidis D, Vagenakis A. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 21: 18-26. PMID 16048797 DOI: 10.1080/09513590500099255 |
0.372 |
|
| 2004 |
Kaloyannidis P, Sakellari I, Fassas A, Fragia T, Vakalopoulou S, Kartsios C, Garypidou B, Kimiskidis V, Anagnostopoulos A. Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a. Bone Marrow Transplantation. 34: 187-188. PMID 15195073 DOI: 10.1038/Sj.Bmt.1704550 |
0.338 |
|
| 2004 |
Athanasiadou A, Stamatopoulos K, Sakellari I, Zorbas I, Gaitatzi M, Fassas A, Anagnostopoulos A. Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia. Bone Marrow Transplantation. 34: 189-191. PMID 15156167 DOI: 10.1038/Sj.Bmt.1704554 |
0.359 |
|
| 2004 |
Schmid C, Labopin M, Finke J, Ehninger G, Ringden O, Niederwieser D, Sakellari I, Urbano-Ispizua A, Ruutu T, Gurman G, Clarke RE, Gorin N, Polge E, Fouillard L, Frassoni F, et al. Retrospective Comparison of Using or Not Using Donor Lymphocyte Transfusion in the Treatment of Hematological Relapse after Allogeneic Stem Cell Transplantation in 489 Adults with Acute Myeloid Leukemia. Blood. 104: 298-298. DOI: 10.1182/Blood.V104.11.298.298 |
0.411 |
|
| 2004 |
Kaloyiannidis P, Kartsios C, Sakellari I, Vadikolia C, Marantidou M, Anagnostopoulos A, Fassas A. Prior Rituximab (RTX) Administration Might Adversely Affect Stem Cell Harvest in Patients with Aggressive B-Cell Lymphomas. Blood. 104: 2887-2887. DOI: 10.1182/Blood.V104.11.2887.2887 |
0.341 |
|
| 2003 |
Christidou F, Athanasiadou A, Kalogiannidis P, Natse T, Bamichas G, Salum R, Sakellari I, Anagnostopoulos A, Fassas A, Sombolos K. Therapeutic plasma exchange in patients with grade 2-3 hematopoietic stem cell transplantation-associated thrombotic thrombocytopenic purpura: a ten-year experience. Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society For Apheresis, the Japanese Society For Apheresis, the Japanese Society For Dialysis Therapy. 7: 259-62. PMID 12918953 DOI: 10.1046/J.1526-0968.2003.00026.X |
0.359 |
|
| 2000 |
Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, Smias C, Eleftheriadis N, Tsimourtou V. Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy. Journal of Clinical Immunology. 20: 24-30. PMID 10798604 DOI: 10.1023/A:1006686426090 |
0.415 |
|
| 1997 |
Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, Tsompanakou A. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study Bone Marrow Transplantation. 20: 631-638. PMID 9383225 DOI: 10.1038/Sj.Bmt.1700944 |
0.352 |
|
| Show low-probability matches. |